Aspire Pharmaceuticals Inc.

Warning letter issued November 22, 2022 · Somerset, New Jersey

Inspection: Nov 29, 2021 – Feb 3, 2022
Pages: 10
FEI number: 3003159106

In short: On November 22, 2022, FDA sent a warning letter to Aspire Pharmaceuticals Inc. in Somerset, New Jersey (FEI 3003159106).

Inside this warning letter

The full warning letter

Every page of the warning letter, exactly as written.

Get the full warning letter

This inspection in context

The firm

Aspire Pharmaceuticals Inc. history

All 3 documents on file for this site, in date order, with what was cited at each inspection.

Questions about this warning letter

When was Aspire Pharmaceuticals Inc. inspected by FDA?

The inspection ran Nov 29, 2021 – Feb 3, 2022, and the Warning letter is dated November 22, 2022.

How do I get the full Warning letter for Aspire Pharmaceuticals Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.